Implantable Cardiac Device P-Wave Oversensing Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing implantable medical devices (IMDs) face challenges in reliably sensing cardiac electrical events, particularly in detecting oversensing of atrial P-waves, which can lead to inappropriate inhibition of pacing pulses and incorrect determination of ventricular rates.
Innovation Solution
The IMD is configured to sense cardiac events, identify oversensed P-wave events, and neglect these events in inhibiting pacing pulses and controlling ventricular pacing intervals. This is achieved through a comparative analysis of the maximum peak amplitudes of two different cardiac electrical signals, allowing the device to distinguish between true R-waves and oversensed P-waves.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the IMD senses cardiac electrical events using a single cardiac electrical signal, then the sensing capability is simple, but the reliability of detecting oversensed P-waves is poor
Solution Approach 1:
The patent divides the sensing system into multiple independent sensing channels, each processing a different cardiac electrical signal (e.g., atrial channel and ventricular channel). By segmenting the sensing function across multiple channels with different electrode configurations, the system can compare signals to distinguish true R-waves from oversensed P-waves, thereby improving detection reliability without requiring complex single-channel processing
Solution Approach 2:
The patent introduces an intermediary comparison mechanism that analyzes the relationship between signals from different sensing channels. By using the atrial signal as a reference to evaluate ventricular signal events, the system can identify when P-waves are oversensed as R-waves. This intermediary comparison approach enhances reliability while maintaining manageable device complexity through structured signal evaluation
2Object-affected harmful factors
If the IMD uses extra-cardiovascular electrodes, then the invasiveness is reduced, but the signal strength and reliability of cardiac event sensing deteriorates
Solution Approach 1:
The patent segments the electrode system into extra-cardiovascular electrodes for reduced invasiveness and processes the resulting weaker signals through multiple sensing channels. By dividing the sensing function across channels with different electrode vectors, the system compensates for lower signal strength through comparative analysis, maintaining reliability while preserving the low-invasiveness benefit
Solution Approach 2:
The patent adds a dimensional aspect to signal evaluation by using multiple sensing vectors and channels instead of relying on a single strong signal path. By analyzing cardiac electrical events from multiple spatial dimensions and signal sources, the system can reliably detect true events despite the inherently weaker signals from extra-cardiovascular electrodes, thus maintaining sensing reliability without requiring invasive intracardiac electrode placement
3Measurement precision
If the IMD treats all sensed events equally, then the processing is simple, but the accuracy of determining ventricular rate and detecting tachyarrhythmias deteriorates
Solution Approach 1:
The patent applies local quality differentiation by treating events from different sensing channels with different evaluation criteria. Ventricular events are evaluated using ventricular channel characteristics, while atrial events are evaluated using atrial channel characteristics. This localized, channel-specific processing approach improves measurement precision by applying appropriate detection thresholds and algorithms to each event type, while maintaining manageable complexity through structured, channel-based processing rules
Data Source
AI summary
An implantable medical device performs a method that includes detecting a cardiac event interval that is greater than a P-wave oversensing threshold interval. In response to detecting the cardiac event interval greater than the P-wave oversensing threshold interval, the device determines the amplitude of the sensed cardiac signal and withholds restarting a pacing interval in response to the amplitude satisfying P-wave oversensing criteria. A pacing pulse may be generated in response to the pacing interval expiring without sensing an intrinsic cardiac electrical event that is not detected as a P-wave oversensing event.